Skip to Content

U.S. Overdose Deaths Have Soared During COVID-19 Pandemic

THURSDAY, April 15, 2021 -- There were more than 87,000 drug overdose deaths in the United States from October 2019 to September 2020, the highest of any one-year period since the nation's opioid crisis began in the 1990s, preliminary government data show.

The death toll was 29 percent higher than in the previous 12-month period and the increase was largely driven by illicitly manufactured fentanyl and other synthetic opioids, with stimulant drugs such as methamphetamine also playing a role, the U.S. Centers for Disease Control and Prevention reported. Whites in rural and suburban areas accounted for many of the deaths in the early years of the U.S. opioid epidemic, but the latest data show Blacks being affected disproportionately.

"The highest increase in mortality from opioids, predominantly driven by fentanyl, is now among Black Americans," Nora Volkow, M.D., director of the National Institute on Drug Abuse, said at an addiction conference last week, The New York Times reported. "And when you look at mortality from methamphetamine, it's chilling to realize that the risk of dying from methamphetamine overdose is 12-fold higher among American Indians and Alaskan Natives than other groups." Volkow added that more deaths than ever involved drug combinations, typically of fentanyl or heroin with stimulants.

Overdose deaths fell slightly in 2018 for the first time in decades, but started to climb again the months before the COVID-19 pandemic and had the highest spike in April and May 2020. In the early months of the pandemic, many addiction treatment centers shut down, at least temporarily, and services were reduced at many drop-in centers that offer support, clean syringes, and the overdose-reversal medication naloxone. In many cases, those services have not been fully restored. Also, the drug overdose crisis has received less attention and resources as the country struggles with the COVID-19 pandemic, The Times said.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Read this next

AI System Can Predict Deterioration in COVID-19 Patients in ED

THURSDAY, May 13, 2021 -- An artificial intelligence (AI) system can predict deterioration of COVID-19 patients in the emergency department, according to a study published online...

Pfizer Vaccine Given Final Approval for Use in Adolescents

THURSDAY, May 13, 2021 -- In a decision that clears the way for schools to reopen safely next fall, U.S. health officials on Wednesday gave their final stamp of approval for the...

Neurological Manifestations Prevalent for Inpatients With COVID-19

THURSDAY, May 13, 2021 -- Neurological manifestations are common among patients hospitalized with COVID-19 and are associated with an increased risk for in-hospital mortality,...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.